Clinical Trial Update: Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Nitrocamptothecin in locally recurrent or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED